Genomic study for brain and mental disorders and effectiveness and side effect of pharmacological treatment

Genomic study for brain and mental disorders and effectiveness and side effect of pharmacological treatment - Genomic study for brain and mental disorders and effectiveness and side effect of pharmacological treatment

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000018892

Enrollment

2200

Registered

2015-09-03

Start date

2010-10-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multifactorial psychiatric disorders including schizophrenia, mood disorders, neurocognitive disorders, eating disorders, anxiety disorders, sleep disorders, autism spectrum disorders, substance-related disorders, attention-deficit/hyperactivity disorder, learning disorder

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with psychiatric disorders (schizophrenia, mood disorders, substance related disorders, neurocognitive disorders, eating disorders, anxiety disorders, sleep disorders, autism spectrum disorders, attention-deficit/hyperactivity disorder, learning disorder) and psychiatrically normal controls

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
None	—

Countries

Japan

Contacts

Public ContactItaru Kushima

Nagoya University Graduate School of Medicine

kushima@med.nagoya-u.ac.jp052-744-2282

Outcome results